Cis-urocanic Acid (Cis-UCA) in Patients With Primary or Recurrent Non-muscle Invasive Bladder Cancer
BioCis Pharma Ltd.
Turku University Hospital
Tampere University Hospital
Juha Peltonen, MD
CRST (Clinical Research Services Turku)
Next post in Bladder Cancer Clinical Trials
Want to view more content from Cancer Therapy Advisor?
Register now at no charge to access unlimited clinical news, full-length features, case studies, conference coverage, and more.
Want to read more?
Please login or register first to view this content.